Literature DB >> 18521117

Mechanisms of Disease: the role of stem cells in the biology and treatment of gliomas.

Jörg Dietrich1, Jaime Imitola, Santosh Kesari.   

Abstract

The study of neural stem cell and progenitor cell biology has improved our understanding of the biology of brain tumors in a developmental context. Recent work has demonstrated that brain tumors may harbor small subpopulations of cells that share characteristics of neural stem cells. There is still an ongoing debate about the specific role of these stem-like cells in cancer initiation, development and progression. Nonetheless, the concept of cancer stem cells has offered a new paradigm to understand tumor biology and resistance to current treatment modalities. Molecular aberrations in these cancer stem cells might be crucial targets for therapeutic intervention, with the hope of achieving more durable clinical responses. Recent studies have demonstrated that endogenous and transplanted neural stem cells and progenitor cells show a marked tropism to brain tumors. Although the mechanisms that govern these processes are poorly understood, the use of neural stem cells and progenitor cells as delivery vehicles for molecules toxic to tumors offers a promising experimental treatment strategy. This Review summarizes recent advances in the basic understanding of neural stem cell and cancer stem cell biology and the progress towards translating these novel concepts into the clinic.

Entities:  

Mesh:

Year:  2008        PMID: 18521117     DOI: 10.1038/ncponc1132

Source DB:  PubMed          Journal:  Nat Clin Pract Oncol        ISSN: 1743-4254


  15 in total

Review 1.  Gliomagenesis and the use of neural stem cells in brain tumor treatment.

Authors:  Pragathi Achanta; N I Sedora Roman; Alfredo Quiñones-Hinojosa
Journal:  Anticancer Agents Med Chem       Date:  2010-02       Impact factor: 2.505

Review 2.  Malignant gliomas: new translational therapies.

Authors:  Joohee Sul; Howard A Fine
Journal:  Mt Sinai J Med       Date:  2010 Nov-Dec

Review 3.  Stem cell paracrine actions and tissue regeneration.

Authors:  Priya R Baraniak; Todd C McDevitt
Journal:  Regen Med       Date:  2010-01       Impact factor: 3.806

Review 4.  Applications of neural and mesenchymal stem cells in the treatment of gliomas.

Authors:  Thomas Kosztowski; Hasan A Zaidi; Alfredo Quiñones-Hinojosa
Journal:  Expert Rev Anticancer Ther       Date:  2009-05       Impact factor: 4.512

Review 5.  Tumor initiating cells in malignant gliomas: biology and implications for therapy.

Authors:  Costas G Hadjipanayis; Erwin G Van Meir
Journal:  J Mol Med (Berl)       Date:  2009-02-03       Impact factor: 4.599

6.  Medullary thyroid carcinoma cell lines contain a self-renewing CD133+ population that is dependent on ret proto-oncogene activity.

Authors:  Wen Zhu; Tao Hai; Lei Ye; Gilbert J Cote
Journal:  J Clin Endocrinol Metab       Date:  2009-11-06       Impact factor: 5.958

7.  Suppression of the growth of human colorectal cancer cells by therapeutic stem cells expressing cytosine deaminase and interferon-β via their tumor-tropic effect in cellular and xenograft mouse models.

Authors:  Bo-Rim Yi; Min-Ah Park; Hye-Rim Lee; Nam-Hee Kang; Kelvin J Choi; Seung U Kim; Kyung-Chul Choi
Journal:  Mol Oncol       Date:  2013-01-19       Impact factor: 6.603

8.  MicroRNA-31 is required for astrocyte specification.

Authors:  Gordon P Meares; Rajani Rajbhandari; Magda Gerigk; Chih-Liang Tien; Chenbei Chang; Samuel C Fehling; Amber Rowse; Kayln C Mulhern; Sindhu Nair; G Kenneth Gray; Nicolas F Berbari; Markus Bredel; Etty N Benveniste; Susan E Nozell
Journal:  Glia       Date:  2018-01-30       Impact factor: 7.452

Review 9.  Cediranib: profile of a novel anti-angiogenic agent in patients with glioblastoma.

Authors:  Jörg Dietrich; Daphne Wang; Tracy T Batchelor
Journal:  Expert Opin Investig Drugs       Date:  2009-10       Impact factor: 6.206

10.  Multi-modality therapeutics with potent anti-tumor effects: photochemical internalization enhances delivery of the fusion toxin scFvMEL/rGel.

Authors:  Pål K Selbo; Michael G Rosenblum; Lawrence H Cheung; Wendy Zhang; Kristian Berg
Journal:  PLoS One       Date:  2009-08-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.